Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
cancer
deals
detroit blog main
detroit top stories
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
2
×
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
ac immune
accelerator
acorda therapeutics
aduro biotech
agenus
airbnb
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
amazon web services (aws)
apalutamide
artificial intelligence (a.i.)
athelas
What
companies
2
×
admits
ago
alzheimer’s
big
bio
biotechs
classes
combinator
different
drug
dug
fail
gene
increases
incubator
latest
life
pharmaceutical
plan
prescription
previously
price
prices
raise
roundup
sciences
sizable
start
started
startup
tech
therapies
they’re
typically
welcome
year
years
Language
unset
Current search:
roche
×
photo
×
" san francisco top stories "
×
companies
×
" new york blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More